Your browser doesn't support javascript.
loading
Circulating tumour cells and pathological complete response: independent prognostic factors in inflammatory breast cancer in a pooled analysis of two multicentre phase II trials (BEVERLY-1 and -2) of neoadjuvant chemotherapy combined with bevacizumab.
Pierga, J-Y; Bidard, F-C; Autret, A; Petit, T; Andre, F; Dalenc, F; Levy, C; Ferrero, J-M; Romieu, G; Bonneterre, J; Lerebours, F; Bachelot, T; Kerbrat, P; Campone, M; Eymard, J-C; Mouret-Reynier, M-A; Gligorov, J; Hardy-Bessard, A-C; Lortholary, A; Soulie, P; Boher, J-M; Proudhon, C; Charafe-Jaufret, E; Lemonnier, J; Bertucci, F; Viens, P.
Afiliación
  • Pierga JY; Medical Oncology Department, Institut Curie, PSL Research University, Paris, France.
  • Bidard FC; Medical Oncology Department, Institut Curie, PSL Research University, Paris, France.
  • Autret A; Biostatistics Department, Institut Paoli-Calmettes, Centre de Recherche en Cancérologie de Marseille, Marseille.
  • Petit T; Medical Oncology Department, Centre Paul Strauss, Strasbourg.
  • Andre F; Medical Oncology Department, Gustave Roussy INSERM Unit U981, Université Paris Sud, Villejuif.
  • Dalenc F; Medical Oncology Department, Institut Claudius Regaud, IUCT, Toulouse.
  • Levy C; Medical Oncology Department, Centre François Baclesse, Caen.
  • Ferrero JM; Medical Oncology Department, Centre Antoine Lacassagne, Nice.
  • Romieu G; Medical Oncology Department, Institut du Cancer de Montpellier, Montpellier.
  • Bonneterre J; Medical Oncology Department, Centre Oscar Lambret, Lille.
  • Lerebours F; Medical Oncology Department, Institut Curie, Saint Cloud.
  • Bachelot T; Medical Oncology Department, Centre Léon Bérard, Lyon.
  • Kerbrat P; Medical Oncology Department, Centre Eugène Marquis, Rennes.
  • Campone M; Medical Oncology Department, Institut de Cancérologie de l'Ouest, ICO Angers Nantes.
  • Eymard JC; Medical Oncology Department, Institut Jean Godinot, Reims.
  • Mouret-Reynier MA; Medical Oncology Department, Centre Jean Perrin, Clermont Ferrand.
  • Gligorov J; Medical Oncology Department, Hôpital Tenon, Assistance Publique des Hôpitaux de Paris, Université Pierre et Marie Curie, Paris.
  • Hardy-Bessard AC; Centre Armoricain de Radiothérapie d'Imagerie médicale et d'Oncologie, Plérin.
  • Lortholary A; Centre Catherine de Sienne, Nantes.
  • Soulie P; Medical Oncology Department, Institut de Cancérologie de l'Ouest, ICO Angers Nantes.
  • Boher JM; Biostatistics Department, Institut Paoli-Calmettes, Centre de Recherche en Cancérologie de Marseille, Marseille.
  • Proudhon C; Medical Oncology Department, Institut Curie, PSL Research University, Paris, France.
  • Charafe-Jaufret E; Pathology Department, Institut Paoli-Calmettes, Centre de Recherche en Cancérologie de Marseille, Marseille.
  • Lemonnier J; Aix-Marseille Université, Marseille.
  • Bertucci F; R&D UNICANCER, UCBG, Paris.
  • Viens P; Aix-Marseille Université, Marseille.
Ann Oncol ; 28(1): 103-109, 2017 01 01.
Article en En | MEDLINE | ID: mdl-28177480
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias Inflamatorias de la Mama / Células Neoplásicas Circulantes Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Adult / Aged / Female / Humans / Middle aged Idioma: En Año: 2017 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias Inflamatorias de la Mama / Células Neoplásicas Circulantes Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Adult / Aged / Female / Humans / Middle aged Idioma: En Año: 2017 Tipo del documento: Article